This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Robert J. Ellis, MD; C. Walton Lillehei, PhD, MD; J. B. Zabriskie, MD

JAMA. 1970;211(9):1505-1508.

Abstract
Immunofluorescent heart-reactive antibody was demonstrated in serum samples from three patients with cardiac transplants, one of whom is herewith presented in detail. The presence of this antibody correlated well with subsequent episodes of cardiac rejection. Increasing doses of immunosuppressive therapy had a direct effect on the disappearance of the circulating antibody from the serum samples of these patients. Up to the present, all signs and tests for cardiac rejection have relied upon the detection of the signs and effects of cardiac dysfunction, which of course means that significant damage has already occurred. Assay of heart-reactive antibody may be an early and sensitive indicator of cardiac rejection in patients with cardiac allografts.

Author Affiliations
From the Department of Surgery, the New York Hospital—Cornell Medical Center, and Rockefeller University, New York.

Footnotes
Reprint requests to 525 E 68th St, New York 10021 (Dr. Lillehei).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?